Prime Medicine (PRME) Interest Expenses (2021 - 2026)

Prime Medicine's Interest Expenses history runs 6 years deep, the most recent figure standing at $179.1 million for Q1 2026.

• Quarterly Interest Expenses fell 10.59% year-over-year to $179.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $179.1 million (down 10.59% YoY) and the FY2025 annual result came in at $3000.0, down 100.0% from the prior year.
• Interest Expenses was $179.1 million for Q1 2026 at Prime Medicine, up from $3000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $208.0 million in Q3 2024 and bottomed at $3000.0 in Q4 2025.
• A 5-year average of $111.4 million and a median of $119.2 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses jumped 18124.0% — and 2025, when it sank 100.0%.
• Prime Medicine's Interest Expenses stood at $62.1 million in 2022, then jumped by 91.93% to $119.2 million in 2023, then soared by 50.76% to $179.8 million in 2024, then sank by 100.0% to $3000.0 in 2025, then jumped by 5969233.33% to $179.1 million in 2026.
• Business Quant data shows PRME's Interest Expenses at $179.1 million in Q1 2026, $3000.0 in Q4 2025, and $71.6 million in Q3 2025.